Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-26-044411
Filing Date
2026-04-16
Accepted
2026-04-16 16:32:31
Documents
2
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 20788
2 EXHIBIT 99.1 tm2611944d1_ex99-1.htm EX-99.1 3416
  Complete submission text file 0001104659-26-044411.txt   26218
Mailing Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Business Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014 2123395600
BAKER BROS. ADVISORS LP (Filed by) CIK: 0001263508 (see all company filings)

EIN.: 134093645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A

Mailing Address C/O BEONE MEDICINES I GMBH AESCHENGRABEN 27, 21ST FLOOR BASEL Switzerland 4051
Business Address C/O BEONE MEDICINES I GMBH AESCHENGRABEN 27, 21ST FLOOR BASEL Switzerland 4051 41-616851900
BeOne Medicines Ltd. (Subject) CIK: 0001651308 (see all company filings)

EIN.: 981209416 | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-89331 | Film No.: 26867987
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)